Clinical Characteristics and Related Risk Factors of Thyroid Dysfunction in LADA Patients: A Single-Center Cross-Sectional Study in Xuzhou, Jiangsu, China
Lower FCP, P2hCP, and FT3 levels, along with higher TPOAb and TGAb levels, are associated with thyroid dysfunction in LADA patients. Therefore, it is recommended that LADA patients undergo screening for thyroid antibodies and FT3 at disease onset and every 1-2 years thereafter to minimize the risk of undiagnosed thyroid dysfunction. Additionally, reassessment of pancreatic function every 3-6 months is advised to optimize the timing of insulin therapy.
Authors
- Qian Lü (ORCID: https://orcid.org/0000-0003-2611-3284)
- Dan Peng (ORCID: https://orcid.org/0000-0002-3207-5723)
- Hua Zhang (ORCID: https://orcid.org/0000-0003-0727-7478)
- Jing Wei (ORCID: https://orcid.org/0000-0002-8803-7056)
- Cheng Xu (ORCID: https://orcid.org/0000-0002-7228-508X)
Institutions
- Xuzhou Medical College (CN)
- Shangluo University (CN)
- Shangqiu First People's Hospital (CN)
- Taian City Central Hospital (CN)
- Shangluo Central Hospital (CN)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/dmso.s547172
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00